Neural Stem Cell-conditioned Medium Protected Against Cognitive Dysfunction in APP/PS1 Mice

Area of Science:

• Neuroscience
• Regenerative Medicine
• Pharmacology

Background:

• Neural stem cell conditioned medium (NSC-CM) demonstrates therapeutic potential in regenerative medicine.
• Previous research indicated NSC-CM mitigates apoptosis in Alzheimer's disease (AD) cell models.

Purpose of the Study:

• To investigate the neuroprotective capacity of NSC-CM against cognitive decline in a mouse model of AD.
• To evaluate the effects of NSC-CM on amyloid-beta (Aβ) plaque load, tau phosphorylation, and neuroinflammation.

Main Methods:

• APP/PS1 transgenic mice, an AD model, received daily tail vein injections of NSC-CM or PBS for 7 or 14 days.
• Cognitive and emotional behaviors were assessed using the new object recognition test (NORT) and open field test (OFT).
• Levels of p-Tau, NLRP3, caspase-1, IL-1β, Aβ plaque load, and astrocyte activity were analyzed.

Main Results:

• NSC-CM treatment significantly improved cognitive and emotional deficits in APP/PS1 mice.
• Reduced amyloid-beta plaque burden and phosphorylated tau levels were observed.
• NSC-CM enhanced astrocyte phagocytosis and suppressed neuroinflammation by inhibiting NLRP3 inflammasome activation (NLRP3, caspase-1, IL-1β).

Conclusions:

• NSC-CM effectively ameliorates cognitive dysfunction and key pathological hallmarks of AD in a mouse model.
• NSC-CM demonstrates potential as a novel therapeutic strategy for Alzheimer's disease.